GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
15.5567 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CA2, CA3, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MMP2, NR1H4, POLB, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
14.8764 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA3, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, GSK3B, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, INSR, MMP2, MMP9, NR1H4, POLB, PPARA, PTGS2, RORC, SRC, TEK, TYR |
14.4579 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DHFR, DRD1, DRD2, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, KIT, MET, NR1H4, POLA1, POLB, PPARA, PTGS2, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, XDH |
13.9416 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DHFR |
13.5311 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CA2, CA3, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MMP2, MMP9, NR1H4, POLB, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, TYR |
13.1566 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, FABP3, FUT7, GBA2, GLO1, HMGCR, HSPA1A, IDO1, NR1H4, PIM1, PPARA, PTGS2, TBXAS1, TYR, XDH |
13.1566 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
13.0649 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
12.9944 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
12.9633 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MET, NR1H4, PPARA, PTGS2, TBXAS1 |
12.8153 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.7268 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
10.9495 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
10.7223 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NR1H4 |
10.2226 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
10.2226 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, THRA, TOP2A, XDH |
10.1511 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS2, SMAD3, SRC, TEK, TERT, XDH |
10.0822 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, TBXAS1, TYR, XDH |
10.0822 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, THRA, TOP2A, XDH |
10.0644 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, GSK3B, HSD11B2, IGF1R, INSR, KIT, MMP2, NR1H4, PPARA, PTGS2, SMAD3, SRC, TEK |
10.0538 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
9.54621 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
9.54621 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, ESRRA, F10, F3, FABP4, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IDO1, INSR, KDR, KIT, MET, MMP12, MMP2, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, TNKS2, XDH |
9.4905 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
9.4905 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CDK6, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, NR1H4, NUAK1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, TOP2A, TYR |
9.46846 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
9.21093 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
9.11288 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD17B2, INSR, KDR, KIT, MET, MMP2, MMP9, PIM1, POLB, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS2, TOP2A, TYR |
9.08859 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
8.9514 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, THRA, TOP2A, XDH |
8.9096 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
8.85752 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, THRA, TNKS, TNKS2, XDH |
8.71002 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, IDO1, NR1H4, PTGS2, RORC, SRC, TYR |
8.68657 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, EGFR, ESR1, ESRRA, FLT3, HSD11B2, PTGS2, RORC, SRC, TEK, TYR |
8.63673 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
8.60985 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, KIT, MET, PTGS2, PTPN1, SRC, TEK, XDH |
8.60985 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
8.58815 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, THRA, TNKS, TNKS2, XDH |
8.57301 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, INSR, KIT, PPARA, PTGS2, SRC, TEK |
8.56845 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, GPR35, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, THRA |
8.46313 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT |
8.42607 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, NR1H4, PTGS2, RORC, SMAD3, SRC, TERT |
8.39568 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP2, MMP9, NR1H4, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, THRA, TNKS, TNKS2, XDH |
8.3636 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP9, NR1H4, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
8.35166 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
8.32791 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
8.20247 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA3, CDC25B, CDK6, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLB, PTGS2, PTPN1, SRC, TEK, TNKS, XDH |
8.19613 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, APEX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
8.12192 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, EGFR, FABP3, FABP4, FUT7, GBA2, HMGCR, KIT, MET, PPARA, PTGS2, TBXAS1 |
8.00697 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
7.98445 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HMGCR, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTGS2, TEK, TERT |
7.96166 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, NR1H4, NUAK1, POLA1, POLB, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TOP2A |
7.92548 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CDK6, CYP19A1, DHFR, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, MET, MMP12, MMP2, NR1H4, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.9185 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, INSR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS2, TYR |
7.91093 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2, TBXAS1 |
7.88853 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
7.88853 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NR1H4 |
7.8772 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.8772 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
7.83109 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APEX1, AURKB, AXL, BCL2, CA3, CDC25B, CDK6, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLB, PTGS2, PTPN1, SRC, TEK, TNKS, XDH |
7.75291 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.65859 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2, TBXAS1 |
7.62215 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MMP2, NR1H4, PTGS2, RORC, SMAD3, SRC |
7.5474 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.48585 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CDK6, DRD1, DRD2, EGFR, HMGCR, KDR, NR1H4, PTGS2, SRC, TNKS, TNKS2 |
7.43417 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DAO, DHFR, DRD1, DRD2, GBA2, HMGCR, NR1H4, TYR |
7.35899 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2, TBXAS1 |
7.27353 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.27353 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, PIM1, SRC, TEK |
7.27353 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GBA2, GSK3B, HSD11B1, HSD17B2, INSR, KDR, KIT, MMP9, PIM1, POLB, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, THRA, TYR |
7.19999 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, THRA, TNKS, TNKS2, XDH |
7.16599 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, BCL2, CDK6, CYP19A1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, GSK3B, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.1378 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, BCL2, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH |
7.10175 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, KIT, POLB, PPARA, SMAD3, SRC, TEK, THRA, TYR |
7.0818 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, BCL2, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH |
7.08167 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA3, CA9, CDK6, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, EGFR, FABP3, HMGCR, HSD11B2, KDR, POLB, PTGS2, SRC |
7.07643 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
7.06672 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, EGFR, HMGCR, HSD11B2, HSPA1A, KIT, MMP2, POLB, PPARA, PTGS2, SMAD3, SRC, TEK, TERT, THRA, TYR |
7.04354 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, HMGCR, INSR, KDR, KIT, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.01767 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, HMGCR, INSR, KDR, KIT, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.01767 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, SRC, THRA, THRB |
6.76485 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PIM1, PPARA, RORC, SRC, THRA, THRB |
6.69774 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, GLO1, IDO1, NR1H4, PPARA, PTGS2, TBXAS1 |
6.54059 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH |
6.48407 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.46165 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, POLB, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
6.45781 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, NR1H4, PPARA |
6.44489 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, BCL2, CA2, CDK6, CHRM2, CYP1B1, DRD2, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, GSK3B, HMGCR, HSPA1A, IDO1, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, PIM1, PTGS2, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS2, XDH |
6.4273 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, KIT, MMP9, NR1H4, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.36506 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, HMGCR, KIT, NR1H4, PPARA, PTGS2, RORC, SRC, TEK, THRA |
6.29372 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, KIT, MMP9, NR1H4, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.29258 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DHFR, DRD1, DRD2, EGFR, FABP3, FLT3, GSK3B, HSD11B2, IGF1R, INSR, MMP2, NR1H4, PPARA, PTGS2, SRC, TEK, TYR |
6.08831 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2, TBXAS1 |
6.08379 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CA3, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, EGFR, GSK3B, HSD11B2, HSPA1A, IDO1, KIT, MMP2, MMP9, NR1H4, NUAK1, POLA1, POLB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, THRA, TOP2A |
6.04849 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
6.03138 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DAO, DHFR, FABP3, GBA2, GLO1, IDO1, NR1H4, PIM1, PPARA, PTGS2, TBXAS1, TYR |
6.01925 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, XDH |
6.01925 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, EGFR, HSPA1A, IDO1 |
6.00283 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, NR1H4, POLA1, POLB, SMAD3, SRC, TERT |
5.98909 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, EGFR, F10, F3, INSR, KIT, MET, SRC, TEK, XDH |
5.92308 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TERT |
5.90698 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, SRC, THRA, THRB |
5.80539 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA3, CYP1A1, CYP1B1, DRD1, DRD2, HMGCR, KDR, POLB, SRC |
5.78485 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KIT, MET, MMP9, NR1H4, NUAK1, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, XDH |
5.63484 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, EGFR, ESR1, GSK3B, KIT, PPARA, RORC, SRC, TOP2A |
5.62119 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DHFR, DRD1, DRD2, EGFR, FABP3, FLT3, GSK3B, HSD11B2, IGF1R, INSR, MMP2, NR1H4, PPARA, PTGS2, SRC, TEK, TYR |
5.60178 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DHFR, DRD2, EGFR, PPARA, SMAD3 |
5.53285 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.51411 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PTGS2, TBXAS1 |
5.44422 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TNKS |
5.44422 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
5.3957 |
[BP] GO:0022414 |
reproductive process
|
ADRA2C, AKR1B1, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, IDO1, INSR, KIT, MMP2, MMP9, PTGS2, SRC, THRA, THRB, TOP2A |
5.38929 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, KIT, PTPN1, SRC, TEK, XDH |
5.38207 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DAO, DHFR, FABP3, GBA2, GLO1, IDO1, NR1H4, PIM1, PPARA, PTGS2, TBXAS1, TYR |
5.36475 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
5.34154 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2, TBXAS1 |
5.32516 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, DRD2, DUSP3, ESR1, FABP4, GPR35, GSK3B, HMGCR, IGF1R, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
5.25143 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DAO, DHFR, FABP3, GBA2, GLO1, IDO1, NR1H4, PIM1, PPARA, PTGS2, TBXAS1, TYR |
5.24931 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ADRA2C, ALOX15, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, EGFR, GPR35, GSK3B, HMGCR, HSPA1A, INSR, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SMAD3, SRC, TERT, THRA |
5.20436 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, EGFR, ESR1, F3, FABP4, HMGCR, IDO1, KDR, MET, MMP12, NR1H4, PPARA, PTGS2, SMAD3, TEK |
5.20436 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, KIT, MMP9, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
5.20269 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, F10, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MET, NR1H4, SRC, TEK, TNKS, TOP2A |
5.19551 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.16362 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, KIT, MMP9, PTGS2, TERT |
5.13011 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD2, EGFR, ESRRB, FLT3, HMGCR, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
5.09421 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.09027 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, KIT, MET, SRC, TEK |
5.08908 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, NR1H4, SRC, TEK |
5.0688 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, NR1H4, PPARA |
5.06031 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, AXL, BCL2, CA2, CYP1B1, DRD2, EGFR, ESRRB, F3, HMGCR, HSPA1A, IDO1, KDR, KIT, MET, MMP12, MMP9, NR1H4, PIM1, PTGS2, SMAD3, SRC, TEK, TERT |
5.06031 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, KDR, KIT, PTPN1, SRC, TEK, XDH |
5.03174 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2, SRC, TEK |
5.03174 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK, THRA |
4.93299 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTGS2, TERT |
4.93016 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
4.92592 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, NUAK1, PIM1, POLA1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
4.86144 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DAO, FABP3, FABP4, FUT7, GBA2, GSK3B, HSPA1A, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.78039 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, DRD1, EGFR, ESR1, GSK3B, IGF1R, INSR, MMP2, MMP9, NR1H4, PTGS2, RORC, SRC |
4.75443 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
4.73996 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CDC25B, CDK6, CYP1A1, DRD1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, KDR, KIT, MET, MMP2, MMP9, PTGS2, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TOP2A |
4.70939 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, NR1H4, PPARA, PTGS2, SRC, TEK |
4.70134 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, EGFR, NR1H4, PTGS2, TNKS, TNKS2 |
4.69835 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
4.69835 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APEX1, AURKB, BCL2, CSNK2A1, DHFR, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
4.68412 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, GSK3B, HMGCR, HSPA1A, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.66236 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, GSK3B, HMGCR, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
4.64749 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, DHFR, DRD2, EGFR, ESR1, ESR2, F3, FLT3, GSK3B, HSPA1A, INSR, KIT, MET, MMP9, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, XDH |
4.64411 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.63927 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, DRD1, EGFR, ESR1, FLT3, GSK3B, IGF1R, INSR, KIT, MMP2, NR1H4, PTGS2, SMAD3, SRC |
4.61946 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DUSP3, ESR1, HMGCR, HSPA1A, IGF1R, MET, MMP9, NR1H4, PTGS2, PTPN1, SRC, XDH |
4.58703 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, NUAK1, PIM1, POLA1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
4.58703 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, BCL2, DRD2, DUSP3, EGFR, ESR1, ESR2, GSK3B, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH |
4.57129 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, GSK3B, HMGCR, HSPA1A, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.52716 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, IDO1, MMP12, MMP2, NR1H4, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
4.52586 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, BCL2, CDC25B, DHFR, DRD2, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, INSR, KIT, PTPN1, SMAD3, SRC, TEK, TERT, TNKS, XDH |
4.50087 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, NUAK1, PIM1, POLA1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
4.46132 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRA2C, AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, EGFR, ESR1, ESRRA, ESRRB, F3, GSK3B, HMGCR, IDO1, INSR, KDR, KIT, NR1H4, NUAK1, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK, TERT, THRA, TNKS2, XDH |
4.4343 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, NUAK1, PIM1, POLA1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
4.39911 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, NR1H4, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, TOP2A |
4.37251 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP9, NR1H4, NUAK1, PIM1, POLA1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
4.34271 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, GSK3B, HMGCR, IGF1R, INSR, KIT, PTPN1, SRC, TEK, TNKS |
4.33333 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.31375 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, DRD2, HMGCR, SRC, TNKS, TNKS2 |
4.23597 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, NR1H4, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, TOP2A |
4.21329 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APEX1, AURKB, BCL2, CSNK2A1, DHFR, DRD2, DUSP3, ESR1, ESR2, ESRRA, FABP4, GSK3B, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
4.17864 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ADRA2C, AXL, BCL2, CA2, CYP1B1, DRD2, ESRRB, F3, HMGCR, IDO1, INSR, KDR, KIT, NR1H4, PIM1, PTGS2, SMAD3, SRC, TEK, TERT, THRA |
4.15576 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK, TNKS |
4.15368 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, GSK3B, KDR, SMAD3, SRC, TEK |
4.11505 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, AURKB, BCL2, CDC25B, CDK6, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT, TNKS, TOP2A |
4.11429 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
4.11254 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2, SRC, TEK |
4.11254 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA2A, ADRA2C, CHRM2, KIT, PTGS2 |
4.1016 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, BCL2, DRD2, ESR1, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.05505 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, KIT, PTPN1, SRC |
4.0512 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, ADRA2C, BCL2, DRD2, GPR35, GSK3B, HMGCR, HSPA1A, MMP9, NR1H4, PTGS2, THRA |
4.03877 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, EGFR, GSK3B, INSR, MMP12, NR1H4, PTGS2, SMAD3, SRC, TERT |
4.03048 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CA3, CYP1B1, EGFR, HSPA1A, MMP9, PTGS2, SRC |
4.02171 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SRC, TEK, XDH |
4.01954 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC, TEK |
4.01928 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
4.00297 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, NR1H4, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, TOP2A |
3.98867 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
3.98867 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR, IDO1 |
3.97385 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, GSK3B, HSD11B2, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
3.9653 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, PTGS2, RORC, SRC |
3.94296 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, DRD1, EGFR, KDR, PTGS2, SRC |
3.927 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, CYP3A4, DAO, DHFR, HMGCR, TYR |
3.90533 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, CHRM2, DRD2, EGFR, PTGS2, THRA, THRB |
3.89107 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, NR1H4, SRC, TEK |
3.87691 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, RORC |
3.86674 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, CHRM2, DRD2, EGFR, GPR35, KIT, PTGS2, SMAD3, THRA, THRB |
3.85754 |
[BP] GO:0051172 |
None
|
ADRA2A, APEX1, AURKB, CSNK2A1, DHFR, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSPA1A, IGF1R, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
3.80142 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, GSK3B, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.7817 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, DHFR, EGFR, INSR, PTGS2, SMAD3, XDH |
3.78003 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, NR1H4, PPARA, SMAD3, TEK |
3.74533 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, CA2, DRD2, EGFR, GSK3B, HMGCR, MMP12, NR1H4, PTGS2, PTPN1, SMAD3, SRC, THRA |
3.73348 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD1, DRD2, EGFR, PTGS2 |
3.70719 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AXL, BCL2, CA1, CA2, CDK6, CHRM2, CSNK2A1, CYP1B1, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GSK3B, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLB, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, THRA, THRB, TNKS, TNKS2 |
3.70114 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.69764 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DAO, DRD1, DRD2, TYR |
3.6944 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2 |
3.64818 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2 |
3.64818 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, GSK3B, KDR, SMAD3, TEK |
3.6363 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, HMGCR |
3.62829 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGS2 |
3.58574 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IDO1, NR1H4, PPARA, PTGS2, SMAD3, TEK |
3.56811 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9, PTGS2, TERT |
3.56634 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, NR1H4, SMAD3 |
3.5625 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.5584 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.55427 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
CDK6, DHFR, DUSP3, EGFR, GSK3B, HMGCR, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, TERT, XDH |
3.54838 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SMAD3, SRC, TERT, TNKS, TOP2A |
3.54468 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
ADRA2C, AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, EGFR, ESR1, ESRRA, F3, GSK3B, HMGCR, IDO1, INSR, KDR, KIT, NR1H4, PIM1, PTGS2, SMAD3, SRC, TEK, TERT, XDH |
3.53103 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, KIT, PTPN1, SRC, TEK |
3.52105 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, KIT, MET, PIM1, POLA1, SRC, TEK, TYR |
3.51653 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, DRD1, EGFR, GSK3B, IGF1R, INSR, MMP2, NR1H4, PTGS2, SRC |
3.51026 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.49867 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.49867 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2 |
3.49867 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, CDK6, GSK3B, KDR, SMAD3, SRC, TEK |
3.4876 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, EGFR, FABP3, HSD17B2, KDR, MMP2, NR1H4, PTGS2, SRC |
3.48364 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, EGFR, HMGCR, PTGS2 |
3.48324 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, TOP2A |
3.48289 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2 |
3.452 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, DRD1, DRD2, EGFR, INSR, PTGS2, SMAD3 |
3.44411 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.39779 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.38866 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.38064 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, KIT, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
3.35298 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, BCL2, DRD2, GPR35, MMP9, PTGS2 |
3.32786 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, CDC25B, DRD2, EGFR, FLT3, INSR, KIT, PTPN1, SRC, TEK, TNKS |
3.31615 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, KIT, PTPN1, SRC |
3.28154 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, GSK3B, MET, MMP9, PPARA, SMAD3, SRC, TERT, TNKS |
3.26522 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 |
3.26163 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
3.26133 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, KIT, PTGS2, SRC |
3.26033 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, GSK3B, MET, MMP9, PPARA, SRC, TERT |
3.24592 |
[BP] GO:0050890 |
None
|
ADORA1, DRD1, DRD2, EGFR, HMGCR, INSR, KIT, PTGS2, THRA |
3.24467 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
3.24382 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, KIT, MMP9, TERT |
3.23036 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, DRD1, EGFR, GSK3B, IGF1R, INSR, MMP2, NR1H4, PTGS2, SRC |
3.22865 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, DUSP3, EGFR, HMGCR, KDR, PTPN1, SRC, TEK |
3.22489 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.21612 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, AURKB, CSNK2A1, DHFR, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HMGCR, HSPA1A, IGF1R, KDR, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
3.21303 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, KDR, SRC |
3.21133 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, APEX1, BCL2, CSNK2A1, EGFR, ESRRB, GSK3B, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3, THRA |
3.17481 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, HMGCR, NR1H4, PPARA, SMAD3, TEK |
3.17324 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, ADRA2C, BCL2, CSNK2A1, DRD2, EGFR, GSK3B, HMGCR, MMP12, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TERT, THRA |
3.1517 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.13774 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR, PTGS2 |
3.13774 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, GSK3B, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, NR1H4, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.11714 |
[BP] GO:0009416 |
response to light stimulus
|
AURKB, BCL2, DRD1, DRD2, EGFR, HMGCR, KIT, PTGS2, TYR |
3.11041 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, PTGS2, SRC |
3.10722 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, ADRA2C, BCL2, DRD2, EGFR, GSK3B, HMGCR, MMP12, NR1H4, PTGS2, PTPN1, SMAD3, SRC, THRA |
3.10037 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, PTGS2, SRC |
3.07197 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.05839 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CA9, CYP1B1, DHFR, EGFR, GSK3B, HSPA1A, MMP9, NUAK1, POLA1, POLB, PTGS2, PTPN1, SRC, TERT, TOP2A |
3.04765 |
[BP] GO:0007610 |
None
|
BCL2, DRD1, DRD2, EGFR, HMGCR, IDO1, INSR, KIT, PPARA, PTGS2, THRA, THRB |
3.04765 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.0453 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
3.04176 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, CDK6, GSK3B, KDR, SMAD3, TEK |
3.03629 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, DRD2, DUSP3, EGFR, INSR, SRC, TERT |
3.02228 |
[BP] GO:0046888 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2, HMGCR |
3.0187 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.0169 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, ADRA2A, APEX1, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NR1H4, PIM1, POLA1, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, TOP2A |
3.00025 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
2.9977 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, DRD2, EGFR, FLT3, INSR, KIT, PTPN1, SRC, TEK |
2.99735 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, PTGS2 |
2.99288 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, BCL2, DRD2, GPR35, PTGS2 |
2.96237 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD1, DRD2, EGFR, KIT, PTGS2 |
2.95092 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD1, DRD2, EGFR, KIT, PTGS2 |
2.95092 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
2.94748 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
2.94748 |
[BP] GO:0045934 |
None
|
ADRA2A, APEX1, AURKB, DRD2, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2 |
2.94748 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, FLT3, KIT, PTPN1, SRC |
2.93452 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, HMGCR, POLB, PTGS2, TERT |
2.93452 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
2.93441 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, KIT, POLB, TEK, TYR |
2.93347 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.90083 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
2.90083 |
[BP] GO:0007611 |
None
|
DRD1, DRD2, EGFR, HMGCR, INSR, KIT, PTGS2, THRA |
2.88765 |
[BP] GO:0010628 |
positive regulation of gene expression
|
DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, GSK3B, HSPA1A, INSR, KIT, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TOP2A |
2.88765 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, NR1H4, PPARA, SMAD3, TEK |
2.86504 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.85825 |
[BP] GO:0032148 |
None
|
ADRA2A, ADRA2C, INSR, SRC |
2.85429 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AOX1, APEX1, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, NR1H4, POLA1, POLB, PPARA, PTGS2, RORC, SMAD3, TERT, THRA, THRB, TOP2A, TYR, XDH |
2.84877 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, ADRA2C, FLT3, KIT, PTPN1, SRC |
2.84572 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CDK6, CYP1B1, DUSP3, GSK3B, IDO1, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.84291 |
[BP] GO:0008050 |
None
|
THRA, THRB |
2.84291 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.84291 |
[BP] GO:0006286 |
base-excision repair, base-free sugar-phosphate removal
|
APEX1, POLB |
2.84291 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, DRD2, EGFR, INSR, KIT, PTPN1, SRC |
2.83577 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
2.83543 |
[BP] GO:0045741 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.83543 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, TEK, TERT |
2.82683 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR |
2.82006 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, THRA, TYR |
2.81879 |
[BP] GO:0060341 |
regulation of cellular localization
|
ADRA2A, BCL2, CSNK2A1, DRD1, DRD2, EGFR, GSK3B, HMGCR, NR1H4, PTGS2, PTPN1, SMAD3, SRC, TERT, THRA |
2.81254 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, GSK3B, HSPA1A, KDR, KIT, MET, MMP1, SMAD3, SRC, TEK |
2.80694 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, EGFR, GSK3B, HMGCR, MMP12, NR1H4, PTGS2, PTPN1, SMAD3, SRC, THRA |
2.77996 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
2.76505 |
[BP] GO:0051254 |
None
|
DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TOP2A |
2.76335 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.7359 |
[BP] GO:0033604 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.7359 |
[BP] GO:0045742 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
2.73413 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DAO, DRD1, DRD2 |
2.73161 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.69572 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, DRD2 |
2.68568 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, KIT, PTPN1, SRC |
2.68568 |
[BP] GO:0051704 |
multi-organism process
|
ADRA2C, AXL, BCL2, CDK6, CHRM2, CYP1A1, EGFR, HSD11B2, HSPA1A, IDO1, INSR, KDR, MET, MMP1, MMP12, NR1H4, POLA1, SMAD3, SRC |
2.65588 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, BCL2, CYP1B1, DRD1, DRD2, EGFR, HMGCR, HSD11B2, INSR, KIT, PTGS2, SRC, TEK, THRA, THRB, TYR |
2.65344 |
[BP] GO:1901186 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
2.65344 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, BCL2, CDK6, CYP1B1, DRD2, FABP3, HSPA1A, IDO1, PTGS2, SMAD3, TERT, XDH |
2.65078 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.64744 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, F3, GSK3B, HMGCR, IDO1, MMP9, PTGS2, SMAD3, SRC, TOP2A, XDH |
2.62367 |
[BP] GO:0009314 |
response to radiation
|
AURKB, BCL2, DRD1, DRD2, EGFR, HMGCR, KIT, POLB, PTGS2, TYR |
2.62276 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, KIT, MMP9, RORC |
2.61397 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, CDC25B, DRD2, EGFR, FLT3, INSR, KIT, PTPN1, SRC |
2.6128 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, AURKB, AXL, BCL2, CSNK2A1, DRD2, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK, THRA, TNKS, TNKS2, TOP2A |
2.60972 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, EGFR, HMGCR, HSD11B2, IDO1, KIT, MMP12, NR1H4, PTGS2, SMAD3, SRC, TYR |
2.60519 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, EGFR, GSK3B, IGF1R, INSR, KDR, KIT, MET, NUAK1, POLB, PTPN1, SRC, TEK |
2.60519 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, AXL, BCL2, CA2, CDK6, CYP19A1, DRD2, DUSP3, ESR1, ESRRA, HSPA1A, IDO1, KIT, MMP12, MMP2, NR1H4, PTPN1, SMAD3, SRC |
2.60228 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, ADRA2C, CYP19A1, DRD2, EGFR, HMGCR, NR1H4 |
2.59713 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, F3, GSK3B, HMGCR, IDO1, MMP9, PTGS2, SMAD3, SRC, TOP2A, XDH |
2.59237 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, KIT, PTPN1, SRC |
2.58767 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.58392 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.58392 |
[BP] GO:0031326 |
regulation of cellular biosynthetic process
|
ADORA3, ADRA2A, APEX1, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, HSPA1A, IGF1R, INSR, KIT, MET, MMP12, NR1H4, PIM1, POLA1, PPARA, PTGS2, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, TOP2A |
2.57834 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.57155 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APEX1, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, EGFR, HSPA1A, INSR, TERT, TNKS |
2.57155 |
[BP] GO:0045893 |
None
|
DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TOP2A |
2.57155 |
[BP] GO:1903508 |
None
|
DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TOP2A |
2.57155 |
[BP] GO:1902680 |
None
|
DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TOP2A |
2.56846 |
[BP] GO:0030154 |
cell differentiation
|
ALPL, AXL, BCL2, CDK6, CYP1A1, ESR1, FABP4, FLT3, FUT7, GLO1, GSK3B, HMGCR, KDR, KIT, MMP2, MMP9, PTGS2, RORC, SMAD3, THRA, THRB, TOP2A |
2.56505 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
2.55899 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, EGFR, HMGCR, HSD11B2, PTGS2, SRC, TYR |
2.55899 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GSK3B, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLB, PPARA, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A |
2.5533 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, EGFR, HMGCR, KDR, SRC, TEK |
2.55227 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, KIT, SRC |
2.53536 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, DHFR, EGFR, FLT3 |
2.53161 |
[BP] GO:0007612 |
None
|
DRD1, DRD2, HMGCR, INSR, KIT, PTGS2 |
2.53161 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DAO, FABP3, FABP4, FUT7, GBA2, GSK3B, HSPA1A, IDO1, XDH |
2.52332 |
[BP] GO:0006584 |
None
|
AKR1B1, DAO, DRD1, DRD2 |
2.52332 |
[BP] GO:0009712 |
None
|
AKR1B1, DAO, DRD1, DRD2 |
2.52332 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, ADRA2C, PTPN1 |
2.52332 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
2.52332 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, DHFR, HMGCR, IDO1, PTGS2 |
2.51415 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.50887 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.50887 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2 |
2.50887 |
[BP] GO:0045986 |
None
|
ADORA1, ADRA2C, PTGS2 |
2.50887 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.50887 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GSK3B, IGF1R, INSR, KDR, KIT, MET, NR1H4, NUAK1, PIM1, POLB, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A |
2.50313 |
[BP] GO:0036211 |
protein modification process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GSK3B, IGF1R, INSR, KDR, KIT, MET, NR1H4, NUAK1, PIM1, POLB, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A |
2.50313 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, GSK3B, IDO1, MMP12, NR1H4, PTGS2, SMAD3, SRC |
2.49664 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, PTGS2 |
2.49664 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, MMP9 |
2.4863 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, NR1H4, PTGS2, SRC |
2.48029 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, HSD11B2, INSR, PPARA, PTGS2, SRC, TEK |
2.47033 |
[BP] GO:0007200 |
None
|
ADRA2A, CHRM2, DRD1, DRD2, ESR1 |
2.46523 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, IDO1, KDR, MET, PTGS2, SMAD3 |
2.46242 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.46242 |
[BP] GO:0098502 |
DNA dephosphorylation
|
APEX1, POLB |
2.46242 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.46242 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.46242 |
[BP] GO:0006808 |
regulation of nitrogen utilization
|
BCL2, NR1H4 |
2.46242 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GSK3B, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, NR1H4, NUAK1, PIM1, POLB, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A |
2.45755 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.44667 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.44059 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, DRD2, EGFR, HMGCR, MMP12, NR1H4, SRC |
2.43839 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, CDC25B, CYP1A1, DUSP3, INSR, TERT |
2.43027 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP2A6, CYP3A4, DAO, HSPA1A, IDO1, XDH |
2.42442 |
[BP] GO:0016311 |
None
|
ALPL, APEX1, BCL2, CA3, CDC25B, DUSP3, POLB, PTPN1 |
2.423 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, AXL, CYP1A1, DRD1, EGFR, ESR1, KIT, PTGS2, SRC, THRA, THRB |
2.41543 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, XDH |
2.41321 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC, TERT |
2.4112 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.3865 |
[BP] GO:0008150 |
biological_process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
2.38132 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.37944 |
[BP] GO:0008542 |
None
|
DRD1, DRD2, HMGCR, KIT |
2.37466 |
[BP] GO:0051241 |
negative regulation of multicellular organismal process
|
ADORA1, ADRA2C, AXL, BCL2, CDK6, DRD2, EGFR, GPR35, GSK3B, IDO1, NR1H4, PTGS2, SMAD3, TEK, TERT, XDH |
2.37013 |
[BP] GO:0008217 |
None
|
ADORA1, DRD2, HSD11B2, PPARA, PTGS2, SMAD3 |
2.3605 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, F3, GSK3B, HMGCR, IDO1, MMP9, PTGS2, SMAD3, SRC, TOP2A, XDH |
2.35044 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.31376 |
[BP] GO:0007617 |
None
|
DRD1, THRA, THRB |
2.31376 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, NR1H4, PTGS2, SRC |
2.31227 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, ESR1, FABP3, GPR35, NR1H4, SMAD3 |
2.30498 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
BCL2, GSK3B, HSPA1A, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT |
2.30433 |
[BP] GO:1900180 |
regulation of protein localization to nucleus
|
EGFR, GSK3B, PTGS2, SMAD3, SRC, TERT, THRA |
2.29958 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, ALOX15, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, XDH |
2.29666 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 |
2.29666 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, F3, KDR, PTGS2, TEK, TERT |
2.29072 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, KIT, TEK |
2.27717 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, ADRA2C, CHRM2, DRD1, DRD2 |
2.26177 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, PPARA, RORC, TOP2A |
2.25952 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, GSK3B, HSPA1A, MET, MMP1, SRC |
2.25952 |
[BP] GO:0071880 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.25952 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.25952 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.25952 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, PPARA, THRA |
2.25952 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.25952 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, MMP9 |
2.24598 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.24212 |
[BP] GO:0090257 |
None
|
ADORA1, ADRA2A, ADRA2C, CHRM2, KIT, PTGS2, SMAD3 |
2.23235 |
[BP] GO:0007632 |
None
|
DRD1, DRD2, HMGCR, KIT |
2.23235 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.23235 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.21637 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.21637 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.21637 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.21637 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, DRD2, HSPA1A, IDO1, MMP12, PTGS2, SMAD3, SRC |
2.21637 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.21637 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.21637 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.21637 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.21637 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.21637 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.21637 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.21637 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.21637 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.21637 |
[BP] GO:0006937 |
None
|
ADORA1, ADRA2A, ADRA2C, CHRM2, KIT, PTGS2 |
2.21637 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.2055 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.20421 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DAO, FABP3, FABP4, GBA2, GSK3B, HSPA1A, IDO1, SRC, XDH |
2.18775 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, IDO1, MMP12, NR1H4, PTGS2, SMAD3, SRC |
2.16539 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, GSK3B, SRC, TNKS |
2.16539 |
[BP] GO:0019219 |
regulation of nucleobase-containing compound metabolic process
|
ADORA3, ADRA2A, APEX1, AURKB, CA9, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, HSPA1A, IGF1R, INSR, KIT, MET, MMP12, NR1H4, PIM1, POLA1, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, TOP2A |
2.16539 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.16539 |
[BP] GO:0022612 |
gland morphogenesis
|
BCL2, EGFR, POLB |
2.16539 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.16539 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.16539 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, KIT, MET |
2.15964 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, EGFR, HMGCR, HSD11B2, PTGS2, SRC, TYR |
2.15244 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CDK6, CYP19A1, DRD2, DUSP3, IDO1, MMP12 |
2.14527 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.14087 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.14087 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.11318 |
[BP] GO:0008406 |
gonad development
|
BCL2, CYP19A1, ESR1, INSR, KIT |
2.10631 |
[BP] GO:0043412 |
macromolecule modification
|
ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GSK3B, IGF1R, INSR, KDR, KIT, MET, NR1H4, NUAK1, PIM1, POLB, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A |
2.10033 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.08745 |
[BP] GO:0006357 |
None
|
AURKB, CA9, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, GLO1, HSPA1A, KIT, MET, MMP12, NR1H4, PPARA, RORC, SMAD3, TERT, THRA, THRB, TNKS, TOP2A |
2.06489 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.06489 |
[BP] GO:0071875 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.06489 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.06489 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.06489 |
[BP] GO:0019229 |
None
|
ADRA2A, ADRA2C, EGFR, PTGS2 |
2.06489 |
[BP] GO:0031349 |
positive regulation of defense response
|
EGFR, FABP4, HSPA1A, IDO1, MMP12, MMP2, NR1H4, PTGS2, SRC |
2.06489 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
2.06084 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, BCL2, DRD2, EGFR, GSK3B, MMP12, NR1H4, PTGS2, SMAD3, SRC |
2.05865 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, F3, KDR, MMP12, SMAD3, TEK, XDH |
2.05568 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, KIT, MMP1, MMP12, MMP9, SRC, TEK |
2.05189 |
[BP] GO:1901342 |
regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, TEK, TERT, XDH |
2.04895 |
[BP] GO:0001817 |
regulation of cytokine production
|
ADRA2A, AXL, CYP1B1, DRD2, HSPA1A, IDO1, MMP12, NR1H4, PTGS2, SMAD3, SRC |
2.04895 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.04534 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.04534 |
[BP] GO:0099565 |
chemical synaptic transmission, postsynaptic
|
DRD2, GSK3B |
2.04534 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.04534 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.04534 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.04534 |
[BP] GO:0098501 |
polynucleotide dephosphorylation
|
APEX1, POLB |
2.04534 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.04534 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.04534 |
[BP] GO:0060509 |
None
|
THRA, THRB |
2.04534 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.04534 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.04534 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.04534 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.04534 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, EGFR, HMGCR, MMP12, NR1H4, SRC |
2.03845 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.03321 |
[BP] GO:0045932 |
None
|
ADORA1, ADRA2C, PTGS2 |
2.03321 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ADRA2C, ALOX5, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, KIT, MMP9, RORC, SMAD3, SRC |
2.02793 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP3A4, DAO |
2.02793 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, MMP12, NR1H4, SRC |
2.00326 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, AURKB, BCL2, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CDC25B, CDK6, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, INSR, KDR, KIT, MMP2, MMP9, PIM1, POLA1, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TERT, THRA, TNKS, TNKS2, TOP2A, TYR, XDH |
4.95979 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, EGFR, F10, FLT3, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTGS2, PTPN1, TBXAS1 |
4.02367 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, EGFR, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTGS2, TBXAS1 |
3.70305 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CDK6, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
3.11334 |
[CC] GO:0044422 |
organelle part
|
AKR1B1, ALOX5, AOX1, APEX1, AURKB, BCL2, CA4, CA5A, CA5B, CA9, CDC25B, CDK6, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FLT3, FUT7, GBA2, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B2, HSPA1A, IDO1, INSR, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR |
2.76435 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, TEK |
2.67815 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CDK6, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
2.63354 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DRD1, DRD2, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GLO1, GPR35, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, KIT, MET, MMP2, PIM1, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TYR |
2.55111 |
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, APEX1, AURKB, BCL2, CA4, CA5A, CA5B, CDK6, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSPA1A, IGF1R, KDR, KIT, MMP12, MMP2, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
2.53536 |
[CC] GO:0044454 |
None
|
APEX1, AURKB, CSNK2A1, ESR1, NR1H4, POLA1, SMAD3, TERT, THRB, TNKS, TNKS2 |
2.51208 |
[CC] GO:0044446 |
intracellular organelle part
|
AKR1B1, ALOX5, AOX1, APEX1, AURKB, BCL2, CA4, CA5A, CA5B, CA9, CDC25B, CDK6, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FLT3, FUT7, GBA2, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B2, HSPA1A, INSR, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR |
2.46242 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.25952 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA7, CA9, CDC25B, CDK6, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
2.20443 |
[CC] GO:0044424 |
intracellular part
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, AURKB, BCL2, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CA9, CDC25B, CDK6, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
2.16736 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, DRD1, DRD2, EGFR, ESR1, F10, F3, FLT3, GBA2, GLO1, GPR35, GSK3B, IGF1R, INSR, KDR, KIT, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK, TERT |
2.12378 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, BCL2, CA4, CES2, CYP19A1, FLT3, GBA2, HMGCR, HSPA1A, KDR, PTGS2, PTPN1, XDH |
2.08443 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CA4, CHRM2, DRD1, DRD2, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK |
2.00518 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, RORC, SMAD3, TBXAS1, THRA, THRB, TNKS, TYR, XDH |
21.6123 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HMGCR, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
19.275 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
18.6611 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DUSP3, EGFR, F10, F3, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PTGS2, PTPN1, SRC, TBXAS1, TEK, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
17.7426 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
13.1234 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, TBXAS1, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
12.7268 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR1H4, PPARA, PTPN1, RORC, SMAD3, THRA, THRB, TNKS |
11.8707 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.6117 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PTGS2, TBXAS1, TYR, XDH |
11.065 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, TBXAS1, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
11.0622 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1, POLB |
9.66079 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
8.99361 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
8.99361 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, HMGCR, HSD11B2, HSD17B1, IDO1, POLA1, PTGS2, SRC, TBXAS1, XDH |
8.99361 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, RORC, THRA, THRB |
8.3636 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.19613 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TBXAS1, XDH |
8.15704 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
7.97436 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, PTGS2, SRC, TBXAS1 |
7.97436 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, PTGS2, SRC, TBXAS1 |
7.6815 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
7.35784 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CHRM2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, NR1H4, PPARA, RORC, TEK, THRA, THRB |
7.17961 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, NR1H4, RORC |
7.07643 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, DHFR, DRD1, DRD2, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PPARA, SRC, TEK, TOP2A |
7.05068 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TBXAS1, TYR |
6.7141 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
6.64335 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CDK6, CHRM2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, NR1H4, PPARA, RORC, TEK, THRA, THRB |
6.47731 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CHRM2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, NR1H4, PPARA, RORC, TEK, THRA, THRB |
6.13322 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PTGS2, TBXAS1, TYR |
6.08379 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CHRM2, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, NR1H4, PPARA, RORC, SMAD3, TEK, THRA, THRB |
5.90698 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
5.49309 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, ADRA2C, AOX1, APEX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP12, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TOP2A, XDH |
5.45395 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.45395 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR, KIT |
5.04777 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
4.96221 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, GSK3B, HMGCR, HSPA1A, KIT, MET, POLA1, POLB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, THRB, TNKS2, TOP2A |
4.90783 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
4.84755 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, NR1H4, PPARA, RORC |
4.66581 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR, THRA, THRB |
4.63555 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, THRA |
4.50087 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC, THRA |
4.48622 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, POLB, SRC, TEK, TERT |
4.35508 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
4.17598 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DAO, DHFR, EGFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NR1H4, NUAK1, PIM1, POLA1, SRC, TEK, TOP2A, XDH |
4.00408 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APEX1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP12, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TOP2A, XDH |
3.99709 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
3.91099 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.75041 |
[MF] GO:1901338 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2 |
3.66478 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, ADRA2C, AOX1, BCL2, CSNK2A1, DRD2, EGFR, ESR1, ESR2, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SMAD3, TERT, TOP2A, TYR, XDH |
3.60407 |
[MF] GO:0004887 |
None
|
NR1H4, THRA, THRB |
3.49867 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, SRC, TEK |
3.48364 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, BCL2, ESR1, ESRRB, FLT3, GSK3B, NR1H4, PIM1, PPARA, SMAD3, SRC, TERT, THRA |
3.32532 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, DAO, DHFR, EGFR, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, SRC, TEK, TOP2A, XDH |
3.31345 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, DAO, DHFR, EGFR, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, SRC, TEK, TOP2A, XDH |
3.3112 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, ADRA2C, AOX1, BCL2, DRD2, FLT3, HMGCR, KIT, PTGS2, SMAD3, TERT, TOP2A, TYR, XDH |
3.26125 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.25515 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.20299 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.20299 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.17481 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, ADRA2C, AOX1, AXL, BCL2, DAO, DRD2, EGFR, FLT3, HMGCR, KIT, PTGS2, SMAD3, TERT, TOP2A, TYR, XDH |
3.1517 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AOX1, AURKB, AXL, CDK6, CSNK2A1, DAO, DHFR, EGFR, F10, F3, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NR1H4, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
3.11714 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.09423 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.9977 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, HMGCR, MET, PPARA, PTPN1, SMAD3 |
2.97172 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.84291 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.84291 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.84291 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CHRM2, DRD1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, TEK |
2.69947 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CHRM2, DRD1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, TEK |
2.69947 |
[MF] GO:0004935 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.50887 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.49664 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.46242 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.46242 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.46242 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
2.37488 |
[MF] GO:0019900 |
None
|
ADRA2A, AURKB, CDC25B, DUSP3, EGFR, ESR1, GSK3B, POLA1, PTPN1, SMAD3, SRC, TOP2A |
2.361 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.25952 |
[MF] GO:0019901 |
None
|
ADRA2A, CDC25B, DUSP3, EGFR, ESR1, GSK3B, POLA1, PTPN1, SMAD3, SRC, TOP2A |
2.25427 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.21637 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.21637 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.21637 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.21637 |
[MF] GO:0046982 |
protein heterodimerization activity
|
ADORA1, ADRA2A, ADRA2C, AXL, BCL2, DRD2, EGFR, SMAD3, TOP2A, TYR |
2.16539 |
[MF] GO:0008227 |
None
|
ADRA2A, ADRA2C, CHRM2, DRD2 |
2.14087 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, GSK3B, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
2.09964 |
[MF] GO:0005488 |
binding
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HMGCR, HSD11B2, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NUAK1, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TERT, THRA, THRB, TNKS, TNKS2, TOP2A, TYR, XDH |
2.05568 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.04534 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.04534 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.04534 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.00657 |